The largest database of trusted experimental protocols

Victor3 1420 multilabel counter

Manufactured by PerkinElmer
Sourced in United States, Finland, Germany, Poland, France, Italy, China

The Victor3 1420 Multilabel Counter is a versatile laboratory instrument designed for high-throughput sample analysis. It offers precise and reliable measurements for a wide range of assays, including fluorescence, luminescence, and absorbance-based applications. The core function of this product is to accurately quantify and analyze samples in a multiwell plate format.

Automatically generated - may contain errors

218 protocols using victor3 1420 multilabel counter

1

Quantification of Renal Function and Lipocalin-2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Renal function was assessed by measuring plasma urea concentrations (Urea UV enzymatic, colorimetric kit, Diagnosticum Inc., Budapest, Hungary) according to the manufacturer’s protocol, and optical density was read at 340 nm (Victor3™ 1420 Multilabel Counter (PerkinElmer, Wallac Oy, Turku, Finland)). BUN values were calculated from the urea concentrations.
Plasma Lcn-2 protein concentration was assayed by the mouse Lipocalin-2/NGAL DuoSet ELISA Development kit (R&D Systems, Minneapolis, MI, USA). Briefly, 96-well plates (Nunc™ GmbH & Co. KG, Langenselbold, Germany) were coated with capture antibody, and non-specific binding sites were blocked with reagent diluent. Plasma samples were incubated in duplicates for 2 h, and the detection antibody was added. Next, Streptavidin-HRP was linked to the detection antibody, followed by a short incubation with TMB substrate (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Samples were washed between each step (5 times with 300 μL washing buffer) until the addition of the substrate solution. Optical density was read at 450 nm with wavelength correction set to 544 nm (Victor3™ 1420 Multilabel Counter (PerkinElmer, Wallac Oy, Turku, Finland)). Concentrations were calculated using a four-parameter logistic curve fit.
+ Open protocol
+ Expand
2

PM2.5 Cytotoxicity and ROS Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
CellTox Green® cytotoxicity assay (Promega) was employed to evaluate cytotoxicity and used according to the manufacturer's protocol. In brief, 1 × 104 cells/well were plated overnight in a 96-well plate. Cells were treated with PM2.5 (1,000, 5,000 and 10,000 ng/ml) for 48 h. The CellTox green dye was diluted 1/500 in CM and applied to the cells. After 15 min of incubation at RT, fluorescence was measured at 485/535 nm using a VICTOR3 1420 Multilabel Counter (Perkin-Elmer) plate reader. ROS was measured by ROS-Glo H2O2 Assay (Promega) according to the manufacturer's protocol. In short: 1 × 104 cells/well were plated in white, clear-bottom 96-well tissue culture plates, incubated over night to adhere and subsequently exposed to PM2.5 (5,000 and 10,000 ng/ml) for 48 h. The H2O2 substrate solution (25 μM) was added to each well and incubated for 6 h at 37°C in a CO2 incubator. With this, the H2O2 substrate reacts directly with H2O2 in the cells and generates a luciferin precursor. Thereafter, ROS-Glo Detection Solution was added and incubated for 20 min at 25°C to generate a luminescence signal. Luminescence was measured using a VICTOR3 1420 Multilabel Counter (Perkin-Elmer) plate reader.
+ Open protocol
+ Expand
3

Colorimetric MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was determined with the colorimetric MTT assay. HaCaT cells were seeded onto 96-well plates at a density of 2 × 104 cells/well and allowed to reach confluence over 24 h. Solutions of the extracts were mixed with Hank’s balanced salt solution (HBSS; pH 6.0, Capricorn Scientific, Ebsdorfergrund, Germany). Prior to the treatment with the extracts, the cell culture medium was withdrawn, and the cells washed with HBSS. The cells were then exposed to the solutions of the extracts in concentrations of 2.5–250 μL/mL for 2 h. Cells incubated in HBSS were used as a negative control. After 2 h of treatment with the extracts, the cells were washed twice with HBSS and incubated with fresh medium (500 µL/well) for 24 h. A total of 50 µL of the MTT solution (5 mg/mL) was added to each well. After 1 h at 37 °C, the medium was removed, and the cells were lysed. Formazan was dissolved with acidic isopropanol and its quantity quantified spectrophotometrically at 570 nm (1420 Multilabelcounter VICTOR3, PerkinElmer, Waltham, MA, USA). Metabolic activity was expressed as relative to control (untreated cells incubated in HBSS).
+ Open protocol
+ Expand
4

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of CHE on cell viability was detected by using MTT assay as described in the previous report [32] . Exponentially growing cells were seeded into 96-well plates and treated as indicated. The cell viability was examined through incubation of the cells with 1 mg/mL MTT for 4 h. DMSO was then added into solubilize the formazan and shaking in the dark. The absorbance at 570 nm was recorded with a microplate reader (Perkin Elmer, 1420 Multilabel Counter Victor3, Wellesley, MA, USA).
+ Open protocol
+ Expand
5

Quantification of Transduced HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vector transduced HepG2 cells were lysed at 72 hr post-transduction and quantified with 1420 Multilabel Counter Victor 3 (PerkinElmer Waltham, MA) following manufacturers instruction of Luciferase Assay system (Promega Madison, WI). Relative Light Units (RLU) were further normalized with protein concentration and viral copy number (VCN per cell). Protein concentration was determined by the Braford method.
+ Open protocol
+ Expand
6

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was examined by the MTT assay.
Exponentially growing HepG2 cells were seeded onto 96-well plates.
Upon reaching approximately 70–80%, cells were incubated with
a series of concentrations of the test compounds. Then, cell viability
was determined by incubating the cells in a medium containing 1 mg/mL
MTT for 4 h before 100 μL of DMSO was added to solubilize the
formazan. The absorbance at 570 nm was measured with a microplate
reader (PerkinElmer, 1420 Multilabel Counter Victor3, Wellesley, MA,
USA).
+ Open protocol
+ Expand
7

Validating Luciferase Transgene and IFN-β

Check if the same lab product or an alternative is used in the 5 most similar protocols
For validation of luciferase transgene activity, we used the Luciferase Assay System kit as per the manufacturer’s protocol (Promega, Madison, WI, USA). Sample luminescence was read on a 1420 Multilabel Counter VICTOR3 (Perkin Elmer, Waltham, MA, USA). The luminescence results were normalized by protein concentration. Interferon-β detection was performed using the Verikine human IFN beta ELISA kit (PBL Assay Science, Piscataway, NJ, USA) and conditioned medium derived from transduced cell cultures. For p14ARF, we use immunofluorescence and Western blot as previously described (37 (link)–39 (link)), using anti-p14ARF antibody (Santa Cruz Biotechnology, Dallas, TX, USA). Immunofluorescence detection was obtained using EVOS FL Cell Imaging System (Thermo Fisher Scientific).
+ Open protocol
+ Expand
8

Measuring Extracellular ATP Release

Check if the same lab product or an alternative is used in the 5 most similar protocols
Release of extracellular ATP was measured by the luciferin-based ENLITEN ATP Assay System Bioluminescence Detection Kit for ATP Measurement in excess of luciferin and luciferase, as indicated by the manufacturer (FF2000, Promega). Beforehand, 100,000 cells per well were seeded in 12-well plates in the serum-free RPMI1640 medium containing 1% BSA. Cells were allowed to attach overnight and then treated with the drugs as indicated for 24 hours in the presence of 50 μM ecto-ATPase inhibitor (ARL67156, A265, Sigma-Aldrich). Harvested samples were transferred to ice-cold Eppendorf tubes and spun down at 3200 g for 5 minutes at 4°C. The supernatant was transferred to a new ice-cold Eppendorf tube and stored at −80°C until assayed. Cell medium was used for background subtraction. ATP-driven chemiluminescence was recorded at 0.1 s with a 1420 Multilabel Counter VICTOR3 (Perkin Elmer) with the Wallac1420 software. Three biological replicates were given per condition, and the biological replicate was represented by the mean value of two technical duplicates.
+ Open protocol
+ Expand
9

Caspase 3/7 Activity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Caspase 3/7 activity assay kits (Cell Signaling Technology, Inc., Beverly, MA, USA) were utilized to study caspase activities in accordance with the manufacturer’s instructions. Cells were plated into 96-well plates and cultured for 24 h. Cells were incubated with indicated concentrations of LCA with or without pretreatment of CQ (5 μM, 1 h) or specific knock-down of ATG7. Cells were then lysed on ice for 5 min and caspase 3/7 assay reagent (200 μL) was added into each well and incubated for 1 h. Luminescence was detected using a microplate reader (Perkin Elmer, 1420 Multilabel Counter Victor3, Wellesley, MA, USA).
+ Open protocol
+ Expand
10

Antiproliferative Potential of Antimicrobial Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the inhibition of cell proliferation, 100 μl of HEK-293 (ATCC CRL-1573TM) cells (5×103) in media (Eagle's Minimum Essential Medium (EMEM) supplemented with 10% v/v foetal bovine serum) were seeded into 96-well plates containing 100 μL serial dilutions (250–0.244 μM) of the AMP in media and cultured at 37°C, 5% CO2 incubator. After 28 h, 20 μL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) solution (CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay kit, Promega) were added to each well and the plates were incubated for a further 1–2 h at 37°C, 5% CO2 incubator. Cell proliferation was determined by measuring absorbance at 490 nm using a microplate reader (PerkinElmer 1420 Multilabel Counter VICTOR3). Positive and negative controls for inhibition were taken as HEK-293 cells incubated with mytomycin C (5 μg/mL, Sigma Pty Ltd) and HEK-293 cells incubated in media alone, respectively. The percentage of inhibition was calculated using the following formula:
% Inhibition = [(A490 test sampleA490 negative control) / (A490 positive controlA490 negative control)] × 100
The percentage of inhibition was plotted against peptide concentration and linear regression analysis was used to determine the AMP concentration needed to inhibit 50% (IC50) of the HEK-293 cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!